Check out your Company Bowl for anonymous work chats.
We are proud to announce a partnership with XSPRAY PHARMA AB (PUBL) to support the U.S. launch and commercialization of the company’s lead product Dasynoc, an innovative cancer therapy for the treatment of chronic myeloid leukemia and acute lymphatic leukemia. Read more:
EVERSANA and Xspray Pharma AB Announce Partnership
More great news to share from the latest release from Vault Rankings! We’re proud to share that our EVERSANA CONSULTING team across the Asia Pacific region has been ranked by Vault in several categories. Read more:
EVERSANA CONSULTING - APAC Region Receives Vault Award
Together with our partners at Evoke Pharma, we're excited to share the results of our real-world evidence utilization study comparing GIMOTI® and Oral Metoclopramide will be featured as a plenary session at Digestive Disease Week 2023. Read more:
EVERSANA and Evoke Pharma Presenting at Digestive Disease Week 2023
During Black History Month, we are celebrating with internal documentary screenings and live roundtable discussions. A few colleagues graciously participated in an additional Q+A. Read their powerful responses now:
EVERSANA Celebrates Black History Month 2023
In our latest Ask the Experts article, EVERSANA’s Learning and Performance leaders explore market conditions in the oncology space and how adversity and mindset training can propel field teams and fulfill unmet needs. Download now:
Download Now - 1 min read time
There’s a new kid on the block! EVERSANA’s Faruk Capan, Chief Innovation Officer and CEO at EVERSANA INTOUCH says the arrival of ChatGPT and other Generative AI platforms have advanced to such a point to be useful for pharma. “These are amazing, exciting times. It feels similar to when the internet was starting. Now, you don’t need to be a developer or a content creator. You just need to write the correct prompt to have scarily accurate information given back to you. This tool is not just for content creators either, it’s for everyone.” Thank you to Pharmaceutical Executive for the interview! Listen now:
The Explosive Arrival of Chat GPT and Generative AI
What’s better than ‘best?’ The culture at EVERSANA! Join the global team and experience a certified Great Place To Work US atmosphere while pursuing a career with purpose.
Discover the "Best" Culture at EVERSANA!
Are you interested in a Summer Internship where you can get hands-on client work experience and contribute to projects with real impact? Apply for our paid, remote Internship Program today!
Apply for our paid, remote Internship Program today!
This week, MM+M will celebrate its 2023 MM+M 40 Under 40 recipients at a live event in NYC. We’re thrilled that our own Sean Rapson, Managing Director, EVERSANA CONSULTING will be among this year’s winners. Congratulations to Sean and all other MM+M honorees. Read more about Sean here:
40 Under 40: Sean Rapson, EVERSANA
ChatGPT and Generative AI are game changers. Chief Innovation Officer, Faruk Capan, recently spoke with Endpoints News about how this type of technology is revolutionizing pharma marketing and the necessary precautions to take when using it.
Exploring the Potential of Generative AI in Pharma Marketing